Organization | Antalya Training and Govermental Hospital

Antalya Training and Govermental Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Founded: Antalya Turkey (2008)

Organization Overview

First Clinical Trial

2014

NCT02159547

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Antalya Training and Research Hospital | Antalya Traning and Research Hospital | Antalya TRH

Active Ingredients

Drugs in Phase 4 Trials (4)

acetaminophen (tylenol) (1 trial)

dexibuprofen (1 trial)

morphine (1 trial)

sodium chloride (1 trial)

Drugs in Phase 3 Trials (1)

azelastine (astelin) (1 trial)

Drugs in Other Trials (6)

bupivacaine (Exparel) (1 trial)

lidocaine (xylocaine) (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

nifedipine (procardia) (1 trial)

oxygen (1 trial)

tramadol (Ultram) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Migraine Disorders (Phase 4)

Sciatica (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 11